ACUTE-ON-CHRONIC LIVER FAILURE
Clinical trials for ACUTE-ON-CHRONIC LIVER FAILURE explained in plain language.
Never miss a new study
Get alerted when new ACUTE-ON-CHRONIC LIVER FAILURE trials appear
Sign up with your email to follow new studies for ACUTE-ON-CHRONIC LIVER FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood filter shows promise for liver failure patients
Disease control Recruiting nowThis study tests whether a blood-filtering device called DPMAS can help people with acute-on-chronic liver failure, a life-threatening condition. The device removes toxins and inflammatory substances from the blood, which may improve immune function and survival. Forty intensive …
Matched conditions: ACUTE-ON-CHRONIC LIVER FAILURE
Phase: NA • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New device aims to filter toxins in liver crisis
Disease control Recruiting nowThis study tests whether adding the CytoSorb blood-filtering device to standard hospital care can better remove waste products like bilirubin and ammonia in people with sudden worsening of chronic liver disease. Twenty adults with severe liver failure will receive the device for …
Matched conditions: ACUTE-ON-CHRONIC LIVER FAILURE
Phase: NA • Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New blood filter aims to save lives in liver failure and sepsis
Disease control Recruiting nowThis study tests a special blood-filtering device (DPCAS+LPE) in 192 adults with acute-on-chronic liver failure and sepsis. The device removes harmful inflammatory substances from the blood. Researchers will compare survival rates and organ function between patients receiving thi…
Matched conditions: ACUTE-ON-CHRONIC LIVER FAILURE
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New injection shows promise for liver failure in early trial
Disease control Recruiting nowThis Phase 2 trial is testing an experimental drug called F573 in 97 people with acute liver failure or acute-on-chronic liver failure. Participants receive daily injections of F573 or a placebo for 7 days. The main goal is to check safety and side effects, while also looking at …
Matched conditions: ACUTE-ON-CHRONIC LIVER FAILURE
Phase: PHASE2 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Stem cell mystery: why some liver patients Don't get better
Knowledge-focused Recruiting nowThis study reviews medical records of 446 people with hepatitis B-related liver failure who received stem cell therapy. Researchers want to find out why some patients did not improve. The goal is to identify factors that affect treatment success so future patients can benefit mor…
Matched conditions: ACUTE-ON-CHRONIC LIVER FAILURE
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Massive study aims to improve liver transplant decisions
Knowledge-focused Recruiting nowThis study follows 3000 adults with severe liver failure who are being considered for a liver transplant. Researchers want to learn which patients benefit most from the procedure and how to improve survival. The goal is to better guide doctors in making this life-saving decision.
Matched conditions: ACUTE-ON-CHRONIC LIVER FAILURE
Sponsor: European Foundation for Study of Chronic Liver Failure • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Massive registry launched to see if Blood-Filtering device helps sickest patients
Knowledge-focused Recruiting nowThis registry is tracking 3,000 critically ill patients who receive the CytoSorb blood-filtering device in real-world intensive care settings. The goal is to collect data on how the device is used and whether it relates to patient survival. It covers many conditions like sepsis, …
Matched conditions: ACUTE-ON-CHRONIC LIVER FAILURE
Sponsor: CytoSorbents, Inc • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:43 UTC